Abstract: This invention relates to an improved automatic anaesthesia delivery system comprising: (a) at least one of a bispectral index monitor and an anaesthesia vital sign monitor interfaced with a computer to receive input from patient; (b) at least one pump for controlling delivery of drug based on the feedback from patient; (c) said computer having specific software for controlling said pump(s) and for fine tuning the dosage based on patient's response and requirements.

Abstract: An integrated continuous-time active-RC filter comprises a set of opamp integrators with Operational Transconductance Amplifiers (OTAs), and at least one assistant transconductor connected between an input and an output of each of the integrators of the set; wherein the assistant transconductor comprises a plurality of sets of MOSFETS connected in parallel to each other wherein each set of MOSFETS is formed by a pair of MOSFETs connected in series, with one MOSFET of the pair operating in the triode region and the other MOSFET of the pair operating in the saturation region; and wherein the assistant transconductor is configured to inject an assistant current into the output of each of the integrators in the set to enhance the linearity and speed of the opamp integrators of the set.

Abstract: The present invention provides a method of making rare earth (RE) doped optical fiber using BaO as co-dopant instead of Al or P commonly used for incorporation of the RE in silica glass by MCVD and solution doping technique. The method comprises deposition of particulate layer of GeO2 doped SiO2 with or without small P2O5 for formation of the core and solution doping by soaking the porous soot layer into an aqueous solution of RE and Ba containing salt. This is followed by dehydration and sintering of the soaked deposit, collapsing at a high temperature to produce the preform and drawing of fibers of appropriate dimension. The use of Ba-oxide enables to eliminate unwanted core-clad interface defect which is common in case of Al doped fibers. The fibers also show good RE uniformity, relatively low optical loss in the 0.6-1.6 ?m wavelength region and good optical properties suitable for their application in amplifiers, fiber lasers and sensor devices.

Abstract: An integrated continuous-time active-RC filter comprises a set of opamp integrators with Operational Transconductance Amplifiers (OTAs). The filter further includes at least one assistant connected between the input and output of each of the integrators of the set to enhance the linearity and speed of the opamp integrators of the set. The assistant comprises a plurality of sets of transconductors connected in parallel to each other wherein each set of transconductors is formed by a pair of MOSFETs connected in series, with one MOSFET operating in the triode region and the other MOSFET operating in the saturation region. The assistant is configured to provide an assistant current to be injected into the source of each of the integrators in the set to enhance the linearity and speed of the opamp integrators of the set.

Abstract: The present invention is an implementation of a network device called Wireless Manager (WiM) a centralized controller for QoS management of infrastructure WLANs based on the IEEE 802.11 DCF standards. The WiM queues and schedules packets from all the traffic flowing between the Access Points (APs) and the wireline LAN which requires no changes to the AP or the STAs, and can be viewed as implementing a Split-MAC architecture. The objectives of WiM are to manage various TCP performance related issues such as the throughput anomaly when STAs associate with an AP with mixed PHY rates, and upload download unfairness induced by finite AP buffers, and also to serve as the controller for VoIP admission control and handovers, and for other QoS management measures.

Abstract: This invention relates to an improved automatic anaesthesia delivery system comprising: (a) at least one of a bispectral index monitor and an anaesthesia vital sign monitor interfaced with a computer to receive input from patient; (b) at least one pump for controlling delivery of drug based on the feedback from patient; (c) said computer having specific software for controlling said pump(s) and for fine tuning the dosage based on patient's response and requirements.